(1) The National Institutes of Health (referred 
to in this section as the ‘‘NIH’’) is the leading bio-
medical research entity in the world. It supports re-
searchers in every State as they discover treatments 
and cures to prevent and reduce human suffering. 
Thanks in large part to NIH-funded medical re-
search, Americans today are living longer and 
healthier. Life expectancy in the United States has 
jumped from 47 years in 1900 to 78 years in 2009, 
and disability in people over age 65 has dropped 
dramatically in the past 3 decades. 
(2) Over the past 40 years, NIH-supported re-
search contributed to the discovery of 153 new Food 
and Drug Administration-approved drugs, vaccines, 
or new indications for current drugs. 
(3) The application success rate is now at an 
all-time low. From 1980 to 2003, the last year of 
the doubling, the grant application success rate 
ranged between 25 and 35 percent. By 2013, the 
grant success rate had fallen to 16.8 percent. 
(4) Recent Federal funding cuts threaten to di-
minish United States leadership in the world. The 
international community has recognized the role bio-
medical research plays in generating economic 
growth. England, China, Brazil, South Korea, India, 
VerDate Sep 11 2014 
23:03 Sep 29, 2014
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5580.IH
H5580
tkelley on DSK3SPTVN1PROD with BILLS
Singapore, Germany, France and Japan are increas-
ing their investment, despite the worldwide reces-
sion. Only the United States has decreased its in-
vestment, from 0.215 percent of Gross Domestic 
Product in 2003 (the last year of the doubling) to 
0.174 percent in 2013. In 8 years, if current trends 
continue, China will surpass the United States in 
total government biomedical research investment. 
(5) NIH is vital to the United States economy. 
In fiscal year 2012, the NIH extramural program 
supported around 50,000 competitive research 
grants and 300,000 scientists and research per-
sonnel at more than 2,500 universities, medical 
schools, and other research institutions across our 
50 States. 
(6) Economists have estimated the return on 
each dollar of investment in NIH to generate any-
where from $1.80 to $3.20 in economic output. The 
Federal investment of $3,800,000,000 in the Human 
Genome Project from 1988 to 2003 helped drive 
$796,000,000,000 in economic output, which is a re-
turn of $141 for every $1 invested. 
(7) In 2013, sales of products built around li-
censed NIH and Food and Drug Administration in-
VerDate Sep 11 2014 
23:03 Sep 29, 2014
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5580.IH
H5580
tkelley on DSK3SPTVN1PROD with BILLS
ventions included 358 licensees reporting a total of 
$7,000,000,000 in sales. 
(8) The historic doubling of Federal funding for 
the National Institutes of Health ended in fiscal 
year 2003. Since that time, NIH appropriations 
have not kept up with biomedical inflation. NIH has 
lost more than 20 percent of its purchasing power 
for medical research since 2003. 
(9) If NIH had kept up with biomedical infla-
tion, NIH’s appropriation would have totaled 
$37,000,000,000 
in 
2013, 
instead 
of 
the 
$28,900,000,000 that was actually appropriated, a 
loss of $8,100,000,000 or 28 percent. To restore 
funding to the 2003 post-doubling level would re-
quire Congress to appropriate $46,500,000,000 in 
fiscal year 2021, the final year of the Budget Con-
trol Act of 2011 (Public Law 112–25). 
(10) High health care costs from a variety of 
common conditions threaten Federal, State, and 
local budgets, as well as the budgets of American 
families. Recent estimates indicate that the economic 
costs 
of 
Alzheimer’s 
disease 
is 
over 
$200,000,000,000 each year but will rise to over 
$1,000,000,000,000 by 2050 unless a prevention or 
cure is found. In 2006, economists found that a fu-
VerDate Sep 11 2014 
23:03 Sep 29, 2014
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5580.IH
H5580
tkelley on DSK3SPTVN1PROD with BILLS
ture 1 percent reduction in mortality rates from can-
cer would save $500,000,000,000 to current and fu-
ture Americans. A cure for cancer was estimated to 
save $50,000,000,000,000 to Americans, more than 
3 times the gross domestic product of the United 
States in 2012. The Centers for Disease Control and 
Prevention 
reports 
that 
annual 
costs 
from 
undiagnosed diabetes was $245,000,000,000 each 
year. And a recent study projects that by 2030, 
nearly 44 percent of the United States population 
will face some form of cardiovascular disease costing 
a total of $1,208,000,000,000 between 2012 and 
2030. 
(11) Budget cap adjustments are how Congress 
traditionally prioritizes areas of spending that 
produce economic growth and reduce costs that con-
tribute to the Federal debt. 
SEC. 3. CAP ADJUSTMENT. 
Section 251(b)(2) of the Balanced Budget and Emer-
gency Deficit Control Act of 1985 (2 U.S.C. 901(b)(2)) 
is amended— 
(1) by redesignating subparagraph (D) as sub-
paragraph (E); and 
(2) by inserting after subparagraph (C), the fol-
lowing: 
VerDate Sep 11 2014 
23:03 Sep 29, 2014
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5580.IH
H5580
tkelley on DSK3SPTVN1PROD with BILLS
‘‘(D) 
NATIONAL
INSTITUTES
OF 
HEALTH.— 
‘‘(i) IN GENERAL.—If a bill or joint 
resolution making appropriations for a fis-
cal year is enacted that specifies amounts 
for the National Institutes of Health at the 
Department of Health and Human Serv-
ices (75–9915–1–1–552), then the adjust-
ments for that fiscal year shall be the 
amount of additional new budget authority 
provided in that Act for such programs for 
that fiscal year, but shall not exceed— 
‘‘(I) 
for 
fiscal 
year 
2015, 
$3,000,000,000 in additional new 
budget authority; 
‘‘(II) 
for 
fiscal 
year 
2016, 
$6,300,000,000 in additional new 
budget authority; 
‘‘(III) for fiscal year 2017, 
$8,100,000,000 in additional new 
budget authority; 
‘‘(IV) 
for 
fiscal 
year 
2018, 
$10,000,000,000 in additional new 
budget authority; 
VerDate Sep 11 2014 
23:03 Sep 29, 2014
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5580.IH
H5580
tkelley on DSK3SPTVN1PROD with BILLS
‘‘(V) 
for 
fiscal 
year 
2019, 
$12,000,000,000 in additional new 
budget authority; 
‘‘(VI) 
for 
fiscal 
year 
2020, 
$14,100,000,000 in additional new 
budget authority; and 
‘‘(VII) for fiscal year 2021, 
$16,300,000,000 in additional new 
budget authority. 
‘‘(ii) DEFINITIONS.—As used in this 
subparagraph: 
‘‘(I) ADDITIONAL
NEW
BUDGET 
AUTHORITY.—The 
term 
‘additional 
new budget authority’ means the 
amount provided for a fiscal year, in 
excess of $29,926,104,000, in an ap-
propriation Act and specified to sup-
port the National Institutes of Health. 
‘‘(II) NATIONAL INSTITUTES OF 
HEALTH.—The term ‘National Insti-
tutes of Health’ means the appropria-
tions accounts that support the var-
ious institutes, offices, and centers 
VerDate Sep 11 2014 
23:03 Sep 29, 2014
Jkt 039200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5580.IH
H5580
tkelley on DSK3SPTVN1PROD with BILLS